TY - JOUR AU - Chen, W. AU - Sun, K. AU - Zheng, R. PY - 2018 DA - 2018// TI - Cancer incidence and mortality in China, 2014 JO - Chin J Cancer Res VL - 30 ID - Chen2018 ER - TY - JOUR AU - Pang, Y. AU - Kartsonaki, C. AU - Guo, Y. PY - 2018 DA - 2018// TI - Diabetes, plasma glucose and incidence of colorectal cancer in Chinese adults: a prospective study of 0.5 million people JO - J Epidemiol Community Health VL - 72 ID - Pang2018 ER - TY - JOUR AU - Smith, C. A. AU - Kachnic, L. A. PY - 2018 DA - 2018// TI - Evolving treatment paradigm in the treatment of locally advanced rectal Cancer JO - J Natl Compr Cancer Netw VL - 16 ID - Smith2018 ER - TY - JOUR AU - Fokas, E. AU - Ströbel, P. AU - Fietkau, R. PY - 2017 DA - 2017// TI - German Rectal Cancer Study Group. Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer JO - J Natl Cancer Inst VL - 109 ID - Fokas2017 ER - TY - JOUR AU - Roselló, S. AU - Papaccio, F. AU - Roda, D. PY - 2018 DA - 2018// TI - The role of chemotherapy in localized and locally advanced rectal cancer: a systematic revision JO - Cancer Treat Rev VL - 63 ID - Roselló2018 ER - TY - JOUR AU - Aschele, C. AU - Cionini, L. AU - Lonardi, S. PY - 2011 DA - 2011// TI - Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial JO - J Clin Oncol VL - 29 ID - Aschele2011 ER - TY - JOUR AU - Gérard, J. P. AU - Azria, D. AU - Gourgou-Bourgade, S. PY - 2012 DA - 2012// TI - Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer JO - J Clin Oncol VL - 30 ID - Gérard2012 ER - TY - JOUR AU - Allegra, C. J. AU - Yothers, G. AU - O'Connell, M. J. PY - 2015 DA - 2015// TI - Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial JO - J Natl Cancer Inst VL - 107 ID - Allegra2015 ER - TY - JOUR AU - Rödel, C. AU - Graeven, U. AU - Fietkau, R. PY - 2015 DA - 2015// TI - German rectal Cancer study group. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial JO - Lancet Oncol. VL - 16 ID - Rödel2015 ER - TY - JOUR AU - Sereno, M. AU - Gutiérrez-Gutiérrez, G. AU - Rubio, J. M. PY - 2017 DA - 2017// TI - Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy JO - BMC Cancer VL - 17 ID - Sereno2017 ER - TY - JOUR AU - Chang, H. AU - Yu, X. AU - Chen, K. PY - 2018 DA - 2018// TI - Prognostic value of the cycle number of perioperative chemotherapy in Locoregionally advanced rectal Cancer: a propensity score matching analysis JO - J Cancer VL - 9 ID - Chang2018 ER - TY - JOUR AU - Herzog, T. AU - Belyaev, O. AU - Chromik, A. M. PY - 2010 DA - 2010// TI - TME quality in rectal cancer surgery JO - Eur J Med Res VL - 15 ID - Herzog2010 ER - TY - JOUR AU - Trakarnsanga, A. AU - Gönen, M. AU - Shia, J. PY - 2014 DA - 2014// TI - Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment JO - J Natl Cancer Inst VL - 106 ID - Trakarnsanga2014 ER - TY - JOUR PY - 2011 DA - 2011// TI - The global prevalence of Anaemia in 2011 JO - Geneva Switzerland WHO VL - 126 ID - ref14 ER - TY - JOUR AU - McCarthy, K. AU - Pearson, K. AU - Fulton, R. AU - Hewitt, J. PY - 2012 DA - 2012// TI - Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer JO - Cochrane Database Syst Rev VL - 12 ID - McCarthy2012 ER - TY - JOUR AU - Zou, X. C. AU - Wang, Q. W. AU - Zhang, J. M. PY - 2017 DA - 2017// TI - Comparison of 5-FU-based and Capecitabine-based Neoadjuvant Chemoradiotherapy in patients with rectal Cancer: a meta-analysis JO - Clin Colorectal Cancer VL - 16 ID - Zou2017 ER - TY - JOUR AU - Kjellström, J. AU - Kjellén, E. AU - Johnsson, A. PY - 2005 DA - 2005// TI - In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line JO - Acta Oncol VL - 44 ID - Kjellström2005 ER - TY - JOUR AU - Yothers, G. AU - O'Connell, M. J. AU - Allegra, C. J. PY - 2011 DA - 2011// TI - Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses JO - J Clin Oncol VL - 29 ID - Yothers2011 ER - TY - JOUR AU - André, T. AU - Gramont, A. AU - Vernerey, D. PY - 2015 DA - 2015// TI - Adjuvant fluorouracil, Leucovorin, and Oxaliplatin in stage II to III Colon Cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study JO - J Clin Oncol VL - 33 ID - André2015 ER - TY - JOUR AU - Deng, Y. AU - Chi, P. AU - Lan, P. PY - 2016 DA - 2016// TI - Modified FOLFOX6 with or without radiation versus fluorouracil and Leucovorin with radiation in Neoadjuvant treatment of locally advanced rectal Cancer: initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phase III trial JO - J Clin Oncol VL - 34 ID - Deng2016 ER - TY - JOUR AU - Hong, Y. S. AU - Nam, B. H. AU - Kim, K. P. PY - 2014 DA - 2014// TI - Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial JO - Lancet Oncol VL - 15 ID - Hong2014 ER - TY - JOUR AU - Jiao, D. AU - Zhang, R. AU - Gong, Z. PY - 2015 DA - 2015// TI - Fluorouracil-based preoperative chemoradiotherapy with or without oxaliplatin for stage II/III rectal cancer: a 3-year follow-up study JO - Chin J Cancer Res VL - 27 ID - Jiao2015 ER - TY - JOUR AU - Felice, F. AU - Benevento, I. AU - Magnante, A. L. PY - 2017 DA - 2017// TI - Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis: Oxaliplatin in neoadjuvant treatment for rectal cancer JO - BMC Cancer VL - 17 ID - Felice2017 ER - TY - JOUR AU - Zheng, J. AU - Feng, X. AU - Hu, W. PY - 2017 DA - 2017// TI - Systematic review and meta-analysis of preoperative chemoradiotherapy with or without oxaliplatin in locally advanced rectal cancer JO - Medicine (Baltimore) VL - 96 ID - Zheng2017 ER - TY - JOUR AU - Breugom, A. J. AU - Swets, M. AU - Bosset, J. F. PY - 2015 DA - 2015// TI - Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data JO - Lancet Oncol. VL - 16 ID - Breugom2015 ER - TY - JOUR AU - Dossa, F. AU - Acuna, S. A. AU - Rickles, A. S. PY - 2018 DA - 2018// TI - Association between adjuvant chemotherapy and overall survival in patients with rectal Cancer and pathological complete response after Neoadjuvant chemotherapy and resection JO - JAMA Oncol VL - 4 ID - Dossa2018 ER - TY - JOUR AU - Schmoll, H. J. AU - Cartwright, T. AU - Tabernero, J. PY - 2007 DA - 2007// TI - Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients JO - J Clin Oncol VL - 25 ID - Schmoll2007 ER - TY - JOUR AU - Sineshaw, H. M. AU - Jemal, A. AU - Thomas, C. R. PY - 2016 DA - 2016// TI - Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: an analysis from the National Cancer Data Base JO - Cancer. VL - 122 ID - Sineshaw2016 ER -